Clinical SupplementPowered by HealixAI • HSA/FSA Eligible
Spore-Based Bacillus Probiotic
100% spore-based broad-spectrum Bacillus probiotic clinically shown to survive stomach acid, reduce post-meal endotoxemia, and support SIBO-sensitive patients.
Clinically Reviewed by HealixAI Board-Certified Physicians•Gastroenterology & Microbiome Formulary•HCPCS / Code: LMN-213D
HSA / FSA Eligible • Save ~30%
Enlarge1/2 ViewsEnlarge Studio View
Medical Dispensary
Spore-Based Bacillus Probiotic (MegaSpore 4 Billion CFU SIBO-Safe Protocol)
Chart Indication: K58.9 (Irritable bowel syndrome)
Clinical Microbiome & SIBO Management Protocol — Endospore-forming Bacillus clausii, Bacillus subtilis, and Bacillus coagulans survive gastric pH 1.5 intact, germinating in the distal bowel without feeding small-intestinal bacterial overgrowth (SIBO).
$56.00$68.00~$39.20 w/ HSA·FSA
In Stock • Direct Dispatch via Medical Dispensary
Compare stores:
Qualifying Health Goals (HSA/FSA)
- Irritable bowel syndrome
- Abdominal distension (gaseous)
- Noninfective gastroenteritis and colitis
Clinical Guidance & Safety
Clinical Microbiome & SIBO Management Protocol — Endospore-forming Bacillus clausii, Bacillus subtilis, and Bacillus coagulans survive gastric pH 1.5 intact, germinating in the distal bowel without feeding small-intestinal bacterial overgrowth (SIBO).
Want dosing & safety tailored to your lab results and medications?
Sync your health records or ask Healix Medical Intelligence by voice on this page.
